{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:44:10Z","timestamp":1789055050402,"version":"build-2803163510"},"reference-count":41,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>(1) Background: Proton pump inhibitors (PPIs) are commonly prescribed for gastric disorders. In patients with liver cirrhosis, PPI use is associated with an increased risk of spontaneous bacterial peritonitis and increased mortality rates; therefore, they should be used with caution. This study aims to evaluate the appropriateness of PPI prescriptions in hospitalized cirrhotic patients against current clinical guidelines to identify patterns of misuse and guide better prescribing practices. (2) Methods: A retrospective study was conducted on liver cirrhosis inpatients in an internal medicine department from January 2022 to May 2023. The primary measure was the proportion of PPI prescriptions aligned with clinical guidelines. Medical files were entirely reviewed by researchers to assess the appropriateness of PPI prescriptions using the current guidelines. Outcomes included the identification of common reasons for PPI prescription and the rate of inappropriate PPI use among the study population. (3) Results: The study included 189 cirrhotic patients, with PPIs prescribed to 95 (50.2%) patients during hospitalization and 75 (39.7%) patients at discharge. Among those, 47.4% of the inpatients and 34.7% at discharge had no valid indication for PPI administration. The most common reason for PPI prescription during hospital stays was gastritis, followed by antiplatelet use in high-risk patients, ulcers, and upper gastrointestinal bleeding. The most common inappropriate indication was portal hypertensive gastropathy (PHG), followed by treatment with corticosteroids and anticoagulants alone. We did not find an association between PPI administration during hospital stays and infections. Only in 4% of cases patients should have received PPIs and did not. (4) Conclusions: There is a concerning overprescription of PPIs in cirrhotic patients, often deviating from established guidelines. It subjects patients to unnecessary risks. There is an urgent need for increased awareness and adherence to clinical guidelines regarding PPI prescriptions in cirrhotic patients.<\/jats:p>","DOI":"10.3390\/jcm13175155","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T07:45:47Z","timestamp":1725003947000},"page":"5155","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Use of Proton Pump Inhibitors in Patients with Liver Cirrhosis: Real Life Experience"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4338-6107","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Eftimie Spitz","sequence":"first","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5508-2598","authenticated-orcid":false,"given":"Stefan Lucian","family":"Popa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania"},{"name":"2nd Department of Internal Medicine, Emergency County Hospital, 400003 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2951-7085","authenticated-orcid":false,"given":"Simona","family":"Grad","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania"},{"name":"2nd Department of Internal Medicine, Emergency County Hospital, 400003 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan Lucian","family":"Dumitrascu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania"},{"name":"2nd Department of Internal Medicine, Emergency County Hospital, 400003 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-271X","authenticated-orcid":false,"given":"Abdulrahman","family":"Ismaiel","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania"},{"name":"2nd Department of Internal Medicine, Emergency County Hospital, 400003 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6020-4724","authenticated-orcid":false,"given":"Teodora","family":"Surdea-Blaga","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400000 Cluj-Napoca, Romania"},{"name":"2nd Department of Internal Medicine, Emergency County Hospital, 400003 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"ref_1","first-page":"36","article-title":"Liver Disease: Cirrhosis","volume":"511","author":"Baumgartner","year":"2021","journal-title":"FP Essent."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Krag","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/jgh.12790","article-title":"Type 2 diabetes: A risk factor for liver mortality and complications in hepatitis B cirrhosis patients","volume":"30","author":"Hsiang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_4","first-page":"6682581","article-title":"Intestinal Microbiota and Liver Diseases: Insights into Therapeutic Use of Traditional Chinese Medicine","volume":"2021","author":"Wang","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"(2017). Prescribing PPIs. Drug Ther. Bull., 55, 117\u2013120.","DOI":"10.1136\/dtb.2017.10.0541"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1586\/17474124.2015.1057122","article-title":"Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?","volume":"9","author":"Brandl","year":"2015","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lambert, A.A., Lam, J.O., Paik, J.J., Ugarte-Gil, C., Drummond, M.B., and Crowell, T.A. (2015). Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128004"},{"key":"ref_8","first-page":"422","article-title":"Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression","volume":"10","author":"Goel","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5152\/tjg.2022.20689","article-title":"Correlation Between Proton Pump Inhibitors and the Complications of Liver Cirrhosis: A Systematic Review and Meta-Analysis","volume":"33","author":"Hwang","year":"2022","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.3748\/wjg.v25.i33.4933","article-title":"Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis","volume":"25","author":"Kai","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/s0004-2803.202202000-40","article-title":"Safety of Long-Term Proton Pump Inhibitors: Facts and Myths","volume":"59","author":"Chinzon","year":"2022","journal-title":"Arq. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000498967","article-title":"A Study on the Status of Proton Pump Inhibitor Prescriptions Using Diagnosis Procedure Combination Data in Japan","volume":"101","author":"Sakata","year":"2020","journal-title":"Digestion"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/apt.13827","article-title":"The impact of proton pump inhibitor therapy on patients with liver disease","volume":"44","author":"Cole","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Scarpignato, C., Gatta, L., Zullo, A., and Blandizzi, C. (2016). Effective and safe proton pump inhibitor therapy in acid-related diseases\u2014A position paper addressing benefits and potential harms of acid suppression. BMC Med., 14.","DOI":"10.1186\/s12916-016-0718-z"},{"key":"ref_15","unstructured":"National Institute for Health and Care Excellence (NICE) (2019). Gastro-Oesophageal Reflux Disease and Dyspepsia in Adults: Investigation and Management, National Institute for Health and Care Excellence (NICE). NICE Clinical Guidelines, No. 184."},{"key":"ref_16","first-page":"728","article-title":"Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.11622\/smedj.2014087","article-title":"Inappropriate use of proton pump inhibitors in a local setting","volume":"55","author":"Chia","year":"2014","journal-title":"Singap. Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000488506","article-title":"Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge","volume":"26","author":"Gamelas","year":"2019","journal-title":"GE Port. J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/apt.13061","article-title":"Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis","volume":"41","author":"Dultz","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Dutta, A.K., Sharma, V., Jain, A., Elhence, A., Panigrahi, M.K., Mohta, S., Kirubakaran, R., Philip, M., Goenka, M., and Bhatia, S. (2024). Inappropriate use of proton pump inhibitors in clinical practice globally: A systematic review and meta-analysis. Gut.","DOI":"10.1136\/gutjnl-2024-332154"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Garc\u00eda Rodr\u00edguez, L.A., Lanas, A., Soriano-Gabarr\u00f3, M., Vora, P., and Cea Soriano, L. (2020). Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9040928"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.3748\/wjg.14.2980","article-title":"Proton pump inhibitors in cirrhosis: Tradition or evidence based practice?","volume":"14","author":"Lodato","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0168-8278(96)80067-5","article-title":"Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis","volume":"25","author":"Savarino","year":"1996","journal-title":"J. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.3748\/wjg.v16.i46.5869","article-title":"PPIs are not associated with a lower incidence of portal-hypertension-related bleeding in cirrhosis","volume":"16","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-8278(05)80191-6","article-title":"Gastric secretion and peptic ulceration in cirrhosis","volume":"19","author":"Fraser","year":"1993","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0016-5085(60)80132-1","article-title":"Gastric Secretion in Human Hepatic Cirrhosis","volume":"38","author":"Ostrow","year":"1960","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"G951","DOI":"10.1152\/ajpgi.00268.2014","article-title":"Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function","volume":"307","author":"Bajaj","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.clinre.2015.02.012","article-title":"Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature","volume":"39","author":"Qi","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Flores, B., Trivedi, H.D., Robson, S.C., and Bonder, A. (2017). Hemostasis, bleeding and thrombosis in liver disease. J. Transl. Sci., 3.","DOI":"10.15761\/JTS.1000182"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.31264","article-title":"Mortality and Hepatic Decompensation in Patients With Cirrhosis and Atrial Fibrillation Treated With Anticoagulation","volume":"73","author":"Serper","year":"2021","journal-title":"Hepatol. Baltim. Md."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/apt.17297","article-title":"Review article: The safety of anticoagulants and antiplatelet agents in patients with cirrhosis","volume":"57","author":"Ma","year":"2023","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/MEG.0000000000000351","article-title":"Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B","volume":"27","author":"Cui","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10557-021-07170-6","article-title":"Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding","volume":"36","author":"Lee","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1007\/s00134-019-05754-3","article-title":"The effect of systemic corticosteroids on the incidence of gastrointestinal bleeding in critically ill adults: A systematic review with meta-analysis","volume":"45","author":"Butler","year":"2019","journal-title":"Intensive Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","article-title":"Corticosteroids and risk of gastrointestinal bleeding: A systematic review and meta-analysis","volume":"4","author":"Narum","year":"2014","journal-title":"BMJ Open"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","article-title":"Corticosteroids and peptic ulcer: Meta-analysis of adverse events during steroid therapy","volume":"236","author":"Conn","year":"1994","journal-title":"J. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Li, H., Li, N., Jia, X., Zhai, Y., Xue, X., and Qiao, Y. (2022). Appropriateness and Associated Factors of Stress Ulcer Prophylaxis for Surgical Inpatients of Orthopedics Department in a Tertiary Hospital: A Cross-Sectional Study. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.881063"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/ajhp\/zxad009","article-title":"Proton pump inhibitors: Understanding the associated risks and benefits of long-term use","volume":"80","author":"Thurber","year":"2023","journal-title":"Am. J. Health-Syst. Pharm. AJHP Off. J. Am. Soc. Health-Syst. Pharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2022.03.052","article-title":"The Association Between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients With Cirrhosis: A Veterans Affairs Cohort Study","volume":"163","author":"Mahmud","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.gastro.2022.04.039","article-title":"Effects of Proton Pump Inhibitors in Cirrhotic Patients: What Do We Really Know?","volume":"163","author":"Cacciola","year":"2022","journal-title":"Gastroenterology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/17\/5155\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:45:43Z","timestamp":1760111143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/17\/5155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":41,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["jcm13175155"],"URL":"https:\/\/doi.org\/10.3390\/jcm13175155","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}